Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Original publication

DOI

10.1016/s1470-2045(14)70346-8

Type

Journal article

Journal

Lancet Oncol

Publication Date

09/2014

Volume

15

Pages

1058 - 1059

Keywords

Aged, Androgen Antagonists, Benzamides, Cost-Benefit Analysis, Health Care Costs, Humans, Male, Middle Aged, National Health Programs, Neoplasm Invasiveness, Neoplasm Recurrence, Local, Neoplasm Staging, Nitriles, Phenylthiohydantoin, Practice Guidelines as Topic, Prostatic Neoplasms, United States